TA
SRPT icon

Teachers Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Teachers Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$12M Sell
100,525
-33,925
-25% -$4.36M 0.01% 903
2018
Q4 		$14.7M Buy
134,450
+1,534
+1% +$192K 0.02% 733
2018
Q3 		$21.5M Buy
132,916
+39,036
+42% +$5.34M 0.03% 694
2018
Q2 		$12.4M Sell
93,880
-102,742
-52% -$9.69M 0.02% 979
2018
Q1 		$14.6M Sell
196,622
-73,999
-27% -$4.93M 0.02% 868
2017
Q4 		$15.1M Buy
270,621
+11,539
+4% +$611K 0.02% 867
2017
Q3 		$11.8M Buy
259,082
+12,105
+5% +$484K 0.02% 966
2017
Q2 		$8.33M Sell
246,977
-44,016
-15% -$1.43M 0.01% 1091
2017
Q1 		$8.61M Buy
290,993
+68,207
+31% +$2.11M 0.01% 1049
2016
Q4 		$6.11M Buy
222,786
+146,002
+190% +$5.86M 0.01% 1176
2016
Q3 		$4.71M Sell
76,784
-43,968
-36% -$1.33M 0.01% 1228
2016
Q2 		$2.3M Buy
120,752
+4,847
+4% +$89.8K ﹤0.01% 1571
2016
Q1 		$2.26M Buy
115,905
+173
+0.1% +$3.02K ﹤0.01% 1519
2015
Q4 		$4.46M Buy
115,732
+6,413
+6% +$208K 0.01% 1181
2015
Q3 		$3.51M Buy
109,319
+176
+0.2% +$5.97K 0.01% 1259
2015
Q2 		$3.32M Sell
109,143
-3,671
-3% -$75.1K 0.01% 1370
2015
Q1 		$1.5M Buy
112,814
+7,734
+7% +$103K ﹤0.01% 1832
2014
Q4 		$1.52M Hold
105,080
– – ﹤0.01% 1799
2014
Q3 		$2.22M Buy
105,080
+10,341
+11% +$233K ﹤0.01% 1528
2014
Q2 		$2.82M Sell
94,739
-173
-0.2% -$5.47K 0.01% 1406
2014
Q1 		$2.28M Buy
94,912
+40,353
+74% +$1.03M ﹤0.01% 1493
2013
Q4 		$1.11M Buy
54,559
+8,740
+19% +$260K ﹤0.01% 1929
2013
Q3 		$2.16M Buy
45,819
+3,831
+9% +$148K 0.01% 1428
2013
Q2 		$1.6M Buy
+41,988
New +$1.5M ﹤0.01% 1552

Other funds holding SRPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Teachers Advisors's SRPT Position: Q1 2019 in Review

Teachers Advisors reduced its Sarepta Therapeutics (SRPT) stake by 25% in Q1 2019, selling an estimated $4.36M and leaving 100,525 shares worth $12M. The position accounts for 0.01% of the portfolio, ranked #903.

Teachers Advisors first reported a position in SRPT in Q2 2013 and has held it in 24 quarters since. The position peaked at $21.5M in Q3 2018. 371 funds tracked by Wall St. Rank hold SRPT as of Q1 2019.

  • Teachers Advisors held 100,525 shares of Sarepta Therapeutics worth $12M as of Q1 2019.
  • Teachers Advisors sold 33,925 Sarepta Therapeutics shares in Q1 2019, an estimated $4.36M.
  • Sarepta Therapeutics made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #903 holding.
  • Teachers Advisors first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Sarepta Therapeutics position peaked at $21.5M in Q3 2018.
  • 371 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.